Self-Amplifying RNA Vaccines Patent Landscape Report

1    Introduction
2    Executive Summary
3    Global mRNA Vaccine and Therapeutic Market Overview
    3.1    Global mRNA Vaccine and Therapeutic Market Historical Value (2017-2023) 
    3.2    Global mRNA Vaccine and Therapeutic Market Forecast Value (2024-2032)
4    Global mRNA Vaccine and Therapeutic Market Segmentation 
    4.1    Global mRNA Vaccine and Therapeutic Market Share by Type
        4.1.1    Market Overview
        4.1.2    Self-Amplifying mRNA Vaccines
        4.1.3    Non-Amplifying mRNA Vaccines
    4.2    Global mRNA Vaccine and Therapeutic Market Share by Route of Administration
        4.2.1    Market Overview
        4.2.2    Intravenous
        4.2.3    Intramuscular
        4.2.4    Intranasal
        4.2.5    Others
    4.3    Global mRNA Vaccine and Therapeutic Market Share by Therapeutic Area
        4.3.1    Market Overview
        4.3.2    Infectious Diseases 
        4.3.3    Oncological Disorders
        4.3.4    Other Disorders
5    Global Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    Porter’s Five Forces Analysis
    5.3    PESTEL Analysis 
    5.4    Industry Events, Initiatives, and Trends  
    5.5    Value Chain Analysis
6    Global Self-amplifying RNA vaccines Patent Landscape Analysis
    6.1    Patent Distribution by Publication Year
    6.2    Patent Distribution by Application Year
    6.3    Patent Distribution by Priority Year
    6.4     Analysis by Type of Patent
        6.4.1    Granted Patents 
        6.4.2    Patent Application
        6.4.3    Amended Application
        6.4.4    Search Report
    6.5    Analysis by Legal Status
        6.5.1    Active 
        6.5.2    Pending 
        6.5.3    Expired/Discontinued 
    6.6    Analysis by Patent Jurisdiction
    6.7    Analysis by Patent Age
    6.8    Analysis by Cooperative Patent Classification (CPC) Codes
    6.9    Average Time to Publish a Patent
        6.9.1    By Entities
        6.9.2    By Jurisdiction
        6.9.3    By Technology
    6.10    Analysis by Type of Entity (Academic and Non-Academic)
    6.11    Analysis by Top Applicants
    6.12    Analysis by Top Inventors
7    Global Self-amplifying RNA vaccines Patent Analysis by Technology
    7.1    Total Patents by Top Technologies 
    7.2    Time Evolution of Patents by Technology
    7.3    Emerging Technologies
    7.4    Synthetic Carrier
        7.4.1    Time Evolution by Number of Patents
        7.4.2    Time Evolution by Number of Patent Families
        7.4.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.4.4    Analysis by Top Applicants
        7.4.5    Analysis by Top Inventors
    7.5    Viral Vectored
        7.5.1    Time Evolution by Number of Patents
        7.5.2    Time Evolution by Number of Patent Families
        7.5.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.5.4    Analysis by Top Applicants
        7.5.5    Analysis by Top Inventors
    7.6    Electroporation
        7.6.1    Time Evolution by Number of Patents
        7.6.2    Time Evolution by Number of Patent Families
        7.6.3    Analysis by Type of Entity (Academic vs Non-Academic)
        7.6.4    Analysis by Top Applicants
        7.6.5    Analysis by Top Inventors
*Complete technology list will be provided in the report.
8    EMR  Patent Valuation Analysis
    8.1    Assessment Methodology
    8.2    High Value Patents
    8.3    Medium Value Patents
    8.4    Low Value Patents
9    Global Self-amplifying RNA vaccines– Top 10 Players Patent Analysis 
    9.1    Top 10 Entities by Number of Patents
    9.2    Analysis by Publication Year
    9.3    Analysis by Application Year
    9.4    Analysis by Priority Year
    9.5    Analysis by Type of Patent
    9.6    Analysis by Jurisdiction
    9.7    Analysis by Cooperative Patent Classification (CPC) Codes
    9.8    Analysis by Source of Innovation 
    9.9    Analysis by Forward and Backward Citations
    9.10    Analysis by Legal Status
    9.11    Analysis by Patent Age
    9.12    Analysis by Key Inventors
    9.13    Entity Dynamics
        9.13.1    Analysis by Type of Player (Academic vs Non-Academic)
        9.13.2    Analysis by Collaboration 
        9.13.3    Analysis by Technology
        9.13.4    Newcomers 
            9.13.4.1    Start-up Companies
            9.13.4.2    Established Companies
10    Patent Profile of Key Players
    10.1    Gentech Inc . 
        10.1.1    Product Portfolio
        10.1.2    Patent Portfolio by Patent Families
        10.1.3    Time Evolution of Patents
        10.1.4    Geographical Patent Coverage 
        10.1.5    Patent Analysis by Technology
        10.1.6    Patent News and Developments
        10.1.7    Financial Analysis
        10.1.8    SWOT Analysis
    10.2    Novartis AG 
    10.3    Human Genome Sciences, Inc .
    10.4    Immatics Biotechnologies GmbH 
    10.5    Broad Institute Inc.
11    Future Trends
12    Global mRNA Vaccine and Therapeutic Market Landscape (Additional Insight)* 
    12.1    Global Self-amplifying RNA vaccines: Developers Landscape
        12.1.1    Analysis by Year of Establishment
        12.1.2    Analysis by Company Size
        12.1.3    Analysis by Region
    12.2    Global Self-amplifying RNA vaccines: Product Landscape 
        12.2.1    Analysis by Product Type
        12.2.2    Analysis by Technology
        12.2.3    Analysis by Application

*Additional insights are not provided in the standard report.